Contact tracing in low-incidence tuberculosis settings

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 12, 2011, Pages 1566-

  Van Leth, Frank ^a,b   Borgdorff, Martien ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

CONTACT EXAMINATION; DIAGNOSTIC TEST; EDITORIAL; HEALTH PROGRAM; HEALTH STATUS; INCIDENCE; INFECTION PREVENTION; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PREDICTIVE VALUE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; QUANTIFERON TB GOLD TEST; TUBERCULIN TEST; TUBERCULOSIS;

FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 81455155736     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0654     Document Type: Editorial

References (3)

1. Whiting P, Rutjes A W S, Dinnes J, Reitsma J, Bossuyt P M M, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004; 8 (25): 1-234.
2. Grinsdale J A, Ho C S, Banouvong H, Kawamura L M. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis 2011; 15: 1614-1619.
3. Munro S A, Lewin S A, Smith H J, Engel M E, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007; 4: e238.